Precision Medicine Market Size, Share | Forecast 2024 – 2032

Precision Medicine Market – Application (Diagnostics [Genetic, Biomarker Based Tests], Therapeutics [Inhibitor Drugs, Monoclonal Antibodies]), Indication (Oncology, CNS), Technology (Genomics, Bioinformatics), End-user – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Advancements in cancer biology in developed region

3.2.1.2&nbsp;&nbsp;&nbsp;Expanding portfolio of precision medicine drugs

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing adoption of gene therapy

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of precision medicine

3.2.2.2&nbsp;&nbsp;&nbsp;Stringent regulatory norms

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Pipeline analysis

3.5&nbsp;&nbsp;&nbsp; Future market trends

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Diagnostics

5.2.1&nbsp;&nbsp;&nbsp; Genetic tests

5.2.2&nbsp;&nbsp;&nbsp; Biomarker based tests

5.2.3&nbsp;&nbsp;&nbsp; Esoteric tests

5.2.4&nbsp;&nbsp;&nbsp; Other tests

5.3&nbsp;&nbsp;&nbsp; Therapeutics

5.3.1&nbsp;&nbsp;&nbsp; Inhibitor drugs

5.3.2&nbsp;&nbsp;&nbsp; Monoclonal antibodies

5.3.3&nbsp;&nbsp;&nbsp; Cell &amp; gene therapy

5.3.4&nbsp;&nbsp;&nbsp; Antiviral &amp; anti-retroviral drugs

5.3.5&nbsp;&nbsp;&nbsp; Other therapeutics

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Indication, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Oncology

6.3&nbsp;&nbsp;&nbsp; CNS disorders

6.4&nbsp;&nbsp;&nbsp; Immunology

6.5&nbsp;&nbsp;&nbsp; Respiratory diseases

6.6&nbsp;&nbsp;&nbsp; Genetic disorders

6.7&nbsp;&nbsp;&nbsp; Skin diseases

6.8&nbsp;&nbsp;&nbsp; Other indications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Genomics

7.3&nbsp;&nbsp;&nbsp; Bioinformatics

7.4&nbsp;&nbsp;&nbsp; Big data analytics

7.5&nbsp;&nbsp;&nbsp; Biomarker detection

7.6&nbsp;&nbsp;&nbsp; High throughput screening

7.7&nbsp;&nbsp;&nbsp; Other technologies

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-user, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

8.4&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Abbott Laboratories, Inc.

10.2&nbsp;&nbsp;&nbsp; Abbvie, Inc.

10.3&nbsp;&nbsp;&nbsp; AstraZeneca plc

10.4&nbsp;&nbsp;&nbsp; bioMerieux SA

10.5&nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company

10.6&nbsp;&nbsp;&nbsp; Cepheid (Danaher Corporation)

10.7&nbsp;&nbsp;&nbsp; Eli Lilly &amp; Company

10.8&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

10.9&nbsp;&nbsp;&nbsp; GlaxoSmithKline plc

10.10&nbsp;&nbsp;&nbsp; Laboratory Corporation of America Holdings (Covance Inc.)

10.11&nbsp;&nbsp;&nbsp; Myriad Genetics, Inc.

10.12&nbsp;&nbsp;&nbsp; Novartis AG

10.13&nbsp;&nbsp;&nbsp; Pfizer, Inc.

10.14&nbsp;&nbsp;&nbsp; QIAGEN N.V.

10.15&nbsp;&nbsp;&nbsp; Quest Diagnostics

10.16&nbsp;&nbsp;&nbsp; Takeda Pharmaceutical Company Limited

10.17&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

10.18&nbsp;&nbsp;&nbsp; Vyant Bio, Inc. (Cancer Genetics, Inc.) 
&nbsp;

Precision Medicine Market

Get a free sample of this report